Clinical Trials on Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Total 5776 results
-
King Faisal Specialist Hospital & Research CenterCompleted
-
University Hospital, BordeauxRecruitingChronic Myeloid LeukemiaFrance
-
Novartis PharmaceuticalsActive, not recruitingChronic Myeloid LeukemiaJapan, Germany, Canada, Australia, France, Israel, Spain, United States, Greece, United Kingdom, Korea, Republic of, Russian Federation, Argentina, Brazil, Poland, Singapore, Belgium, Mexico
-
Novartis PharmaceuticalsCompleted
-
European LeukemiaNetLudwig-Maximilians - University of Munich; Heidelberg UniversityActive, not recruitingChronic Myeloid LeukemiaGermany, Netherlands
-
Assiut UniversityCompleted
-
Polish Adult Leukemia GroupCompletedChronic Myeloid Leukemia
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
Thomas Ernst, PD Dr. med.AbbVie; Ludwig-Maximilians - University of MunichRecruitingChronic Myeloid LeukemiaGermany
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia, Canada
-
Novartis PharmaceuticalsActive, not recruiting
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsTerminatedLeukemiaUnited States
-
European Society for Blood and Marrow TransplantationNovartisCompletedMyeloid Leukemia, ChronicGermany, Finland, Denmark, Poland, Saudi Arabia, United Kingdom, Israel, Hungary, Russian Federation
-
University of JenaRecruitingChronic Myeloid Leukemia in Myeloid Blast CrisisGermany, Czechia, Russian Federation, Ukraine
-
Radboud University Medical CenterCompletedNeoplasms | Telemedicine | Chronic Myeloid Leukemia | Patient PortalsNetherlands
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownChronic Myeloid LeukemiaGermany, Italy, Austria, Iraq, United States, Brazil, China, Malaysia, Netherlands
-
Uppsala UniversityKarolinska University Hospital; Uppsala University HospitalCompletedHealth Care Quality | Health Care EvaluationSweden
-
Novartis PharmaceuticalsNot yet recruitingPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
Masaryk UniversityActive, not recruitingChronic Myeloid Leukemia, Chronic Phase | Withdrawal;DrugCzechia
-
Il-Yang Pharm. Co., Ltd.RecruitingChronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML, Refractory | CML - Philadelphia ChromosomeTurkey, Korea, Republic of, Russian Federation, Ukraine
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Immunex CorporationWithdrawnAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsRecruitingChronic Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsRecruiting
-
FundaleuRecruiting
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Incyte BioSciences FranceCompletedChronic Myeloid LeukemiaFrance
-
Novartis PharmaceuticalsCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveUnited States, Germany, United Kingdom, Italy, France, Switzerland
-
M.D. Anderson Cancer CenterWyeth is now a wholly owned subsidiary of PfizerCompletedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Hikma Pharmaceuticals LLCCompletedPhiladelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic PhaseEgypt
-
Jonsson Comprehensive Cancer CenterBristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
III. Medizinische Klinik MannheimUnknownLeukemiaSwitzerland, Germany, Spain, Poland, Czech Republic
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Disease | Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase of Disease | Chronic Phase of DiseaseUnited States, Germany, Italy
-
Bio-Path Holdings, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia, Ph1-PositiveUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
Cancer Trials IrelandCompletedLeukemiaUnited States, Ireland, Israel, Germany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Bristol-Myers SquibbCompletedLeukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myeloid Leukemia, Chronic, Accelerated PhaseAustralia, Canada, France, Germany, Italy, Korea, Republic of, Taiwan, Thailand, United States, Spain, Austria, Denmark, Belgium, Sweden, Switzerland, Netherlands, Peru, South Africa, Philippines, Singapore, Russian Federation, Br... and more
-
University of ChicagoRecruitingChronic Myeloid Leukemia | MyelofibrosesUnited States
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Blast CrisisNetherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
-
Hospices Civils de LyonCompletedChronic Myelogenous LeukemiaFrance
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruiting
-
M.D. Anderson Cancer CenterSchering-PloughTerminatedLeukemia, Myeloid, Philadelphia-PositiveUnited States